Bibliographie (2530)
![[Preprint] CoronaVac is 50% effective for reducing symptomatic SARS-CoV-2 infection after the first dose in the setting of high P.1 variant transmission in Brazil](/media/k2/items/cache/08ae461f14a3d195f7e52b850155dc3c_L.jpg)
[Preprint] CoronaVac is 50% effective for reducing symptomatic SARS-CoV-2 infection after the first dose in the setting of high P.1 variant transmission in Brazil
vendredi, 09 avril 2021 05:47 Écrit par Zouhair SouissiEffectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study – medRxiv Commentary on Twitter (thread – click for more) New 50% efficacy study of Brazil-predominant vaccine CoronaVac (by Sinovac) in Manaus ?? among healthcare workers when #P1 ~75% dominant. Not a trial, but the study […]
The post [Preprint] CoronaVac is 50% effective for reducing symptomatic SARS-CoV-2 infection after the first dose in the setting of high P.1 variant transmission in Brazil appeared first on Links Medicus.
Study: Outdoor transmission accounts for 0.1% of Covid-19 cases
jeudi, 08 avril 2021 15:05 Écrit par Zouhair SouissiOutdoor transmission accounts for 0.1% of State’s Covid-19 cases – The Irish Times Related: Systematic review: Outdoor transmission of SARS-CoV-2 and other respiratory viruses. “The odds of indoor transmission was very high compared to outdoors (18.7 times)”
The post Study: Outdoor transmission accounts for 0.1% of Covid-19 cases appeared first on Links Medicus.
WHO Interim statement: A causal relationship between the AstraZeneca COVID-19 vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed
jeudi, 08 avril 2021 15:05 Écrit par Zouhair SouissiInterim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine – World Health Organization Commentary on Twitter (thread – click for more) ? Interim statement of the #COVID19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on the AstraZeneca vaccine https://t.co/p8XMMAiUne pic.twitter.com/7DMRNFxQsX — […]
The post WHO Interim statement: A causal relationship between the AstraZeneca COVID-19 vaccine and the occurrence of blood clots with low platelets is considered plausible but is not confirmed appeared first on Links Medicus.
Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditions
jeudi, 08 avril 2021 15:04 Écrit par Zouhair Souissi6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records – The Lancet Psychiatry Commentaries: 1 in 3 Covid-19 patients are diagnosed with a neuropsychiatric condition in the next six months, large study finds – STAT AND A longer look at COVID-19 and neuropsychiatric outcomes – The […]
The post Large study finds 1 in 3 Covid-19 survivors have subsequent mental health and neurological conditions appeared first on Links Medicus.
Cohort study: One in ten have long-term effects 8 months following mild COVID-19
jeudi, 08 avril 2021 15:04 Écrit par Zouhair SouissiOne in ten have long-term effects 8 months following mild COVID-19 – Karolinska Institutet Original study: Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers – JAMA Commentary on Twitter #LongCovid in #Frontline: JAMA Worrisome! N=323 COVID+ #Healthcare Workers vs. N=1072 w no COVID. At 8 mos, up to 4x […]
The post Cohort study: One in ten have long-term effects 8 months following mild COVID-19 appeared first on Links Medicus.
Study finds low risk of venous thromboembolism in outpatients with Covid-19 – researchers advise against the use of anticoagulants outside clinical trials
jeudi, 08 avril 2021 11:08 Écrit par Zouhair SouissiIncidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California – JAMA Internal Medicine Commentaries: VTE Related to SARS-CoV-2 Infection Less Of a Problem in Outpatients – TCTMD AND No Increase Seen in Outpatient VTE for SARS-CoV-2-Positive Patients – Physician’s Weekly Commentary on Twitter […]
The post Study finds low risk of venous thromboembolism in outpatients with Covid-19 – researchers advise against the use of anticoagulants outside clinical trials appeared first on Links Medicus.
UK regulator confirms that people should continue to receive the COVID-19 vaccine AstraZeneca
jeudi, 08 avril 2021 11:08 Écrit par Zouhair SouissiUK regulator confirms that people should continue to receive the COVID-19 vaccine AstraZeneca – GOV.UK Original report: MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots – Medicines and Healthcare products Regulatory Agency Commentary: Expert reaction to statements from MHRA and EMA in relation […]
The post UK regulator confirms that people should continue to receive the COVID-19 vaccine AstraZeneca appeared first on Links Medicus.
JCVI statement on use of the AstraZeneca COVID-19 vaccine: “JCVI currently advises that it is preferable for adults aged
jeudi, 08 avril 2021 11:08 Écrit par Zouhair SouissiJCVI statement on use of the AstraZeneca COVID-19 vaccine: 7 April 2021 – GOV.UK Commentaries: Covid: Under-30s offered alternative to Oxford-AstraZeneca jab – BBC AND Expert reaction to statements from MHRA and EMA in relation to the AstraZeneca vaccine and rare blood clots and low blood platelets – Science Media Centre
The post JCVI statement on use of the AstraZeneca COVID-19 vaccine: “JCVI currently advises that it is preferable for adults aged <30 years to be offered an alternative COVID-19 vaccine, if available.” appeared first on Links Medicus.
Video: Coronavirus Variants and Vaccines
jeudi, 08 avril 2021 11:08 Écrit par Zouhair SouissiCoronavirus Variants and Vaccines – JAMA
The post Video: Coronavirus Variants and Vaccines appeared first on Links Medicus.
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets. The benefits of the vaccine continue to outweigh the risks for people who receive it.
jeudi, 08 avril 2021 11:08 Écrit par Zouhair SouissiAstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets – European Medicines Agency Commentaries: In rare instances, AstraZeneca’s Covid-19 vaccine linked to blood clots, regulators say – STAT AND Expert reaction to statements from MHRA and EMA in relation to the AstraZeneca vaccine and rare […]
The post AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets. The benefits of the vaccine continue to outweigh the risks for people who receive it. appeared first on Links Medicus.
